menu search

IPO / Sagimet Biosciences sets IPO terms, to raise up to about $80 million

Sagimet Biosciences sets IPO terms, to raise up to about $80 million
Sagimet Biosciences Inc. SGMT, disclosed Monday terms for its initial public offering, in which the California-based biopharmaceutical company focused on developing treatments for nonalcoholic steatohepatitis (NASH) looks to raise up to $79.7 million. The company is offering 4.69 million shares in the IPO, which is expected to price between $15 and $17 a share. Read More
Posted: Jul 10 2023, 07:05
Author Name: Market Watch
Views: 110661

IPO News  

Israeli communications headset maker Silynxcom files for New York IPO

By Market Watch
October 27, 2023

Israeli communications headset maker Silynxcom files for New York IPO

Silynxcom Ltd., an Israeli maker of headsets for military, law enforcement, and homeland security agencies, filed for an initial public offering on Fr more_horizontal

Water treatment company Shimmick to offer 4.55 million shares in IPO priced at $10 to $12 each

By Market Watch
October 24, 2023

Water treatment company Shimmick to offer 4.55 million shares in IPO priced at $10 to $12 each

Shimmick Corp. SHIM, , a water treatment company, set terms for its initial public offering on Tuesday with plans to offer 4.55 million shares, priced more_horizontal

Navan CEO Ariel Cohen talks partnering with Citi

By CNBC Television
October 19, 2023

Navan CEO Ariel Cohen talks partnering with Citi

Ariel Cohen, Navan CEO, joins 'Closing Bell Overtime' to talk partnering with Citi, a possible IPO and more. more_horizontal

IPO market: Companies not finding interest they hoped for, analyst says

By Yahoo Finance
October 12, 2023

IPO market: Companies not finding interest they hoped for, analyst says

"Recent IPO debuts from companies such as Instacart (CART), Arm Holdings (ARM), and Birkenstock (BIRK), have not delivered the performance many invest more_horizontal

Bessemer's Byron Deeter talks movement in the IPO market

By CNBC Television
October 2, 2023

Bessemer's Byron Deeter talks movement in the IPO market

Byron Deeter, Bessemer Venture Partners Partner, joins 'Closing Bell Overtime' to talk the IPO market, Birkenstock's recent valuation announcement and more_horizontal

Weak companies are going public: Slow Ventures' Sam Lessin

By CNBC Television
October 2, 2023

Weak companies are going public: Slow Ventures' Sam Lessin

Sam Lessin, Slow Ventures co-founder, joins 'The Exchange' to discuss late-stage capital funds competing with the public market, lack of investor trus more_horizontal

Ticking Time Bombs: 3 New Stocks to Dump Before the Damage Is Done (IPO)

By InvestorPlace
September 28, 2023

Ticking Time Bombs: 3 New Stocks to Dump Before the Damage Is Done (IPO)

The IPO market in 2023 has been anything but hot. After a record-breaking year in 2021, the appetite for new listings has cooled down significantly, f more_horizontal

IPOs Could Screech to a Halt in a Shutdown

By Barrons
September 27, 2023

IPOs Could Screech to a Halt in a Shutdown

The SEC says it will suspend its processing of IPO registrations if Congress can't pass an appropriations bill by September's end. more_horizontal


Search within

Pages Search Results: